Nasdaq bcrx

BioCryst Pharmaceuticals, Inc. About the company. It is also developing BCX, an oral factor D inhibitor for complement-mediated diseases.

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which sections of the website you find most interesting and useful. See our Cookie Policy for more information. These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds. Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow.

Nasdaq bcrx

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades. BCRX chart. Today 0. Key stats. Market capitalization. Dividend yield indicated.

Full year earnings: EPS and revenues miss analyst expectations Feb Mar

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 2. Amarin Corporation plc. AMRN 1. TG Therapeutics Inc common stock.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 5. Amarin Corporation plc. AMRN 2. TG Therapeutics Inc common stock.

Nasdaq bcrx

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades. BCRX chart.

Holy symbol of ravenkind

Terms of use. AMRN 1. Net cash used or generated for core business activities. The price came from below 7. Can it start over with a move to ATH's? TG Therapeutics Inc common stock. Like other stocks, BCRX shares are traded on stock exchanges, e. Total equity The value of subtracting the total liabilities from the total assets of a company. It has also been approved in Japan, Korea, and China. Analyst rating. See Fair Value and valuation analysis. Future Growth. Free cash flow. The ratio of annual dividend to current share price that estimates the dividend return of a stock.

.

The total amount of income generated by the sale of goods or services related to the company's primary operations. One year price forecast for BioCryst Pharmaceuticals, Inc. You can contact us here. Total liabilities Sum of the combined debts a company owes. Mar Next: —. Previous close. BCRX chart. EN Get started. First quarter earnings: EPS and revenues miss analyst expectations May BCRX reached its all-time high on Mar 9, with the price of Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds. This website uses cookies. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases.